Inhaled therapies offer one of the most direct and effective ways to treat respiratory and systemic conditions.
Yet many treatments fail to reach their full potential due to challenges in formulation, delivery and consistency. MISTI® exists to solve this problem.
We combine scientific expertise, proprietary technology and practical application to help pharmaceutical teams develop inhaled therapies that perform as intended in the real world.
Even with strong compounds, inconsistent delivery limits performance and predictability.
MISTI® provides the tools and expertise to improve how inhaled therapies are developed and delivered.
Our approach focuses on:
Millions of patients and billions in healthcare costs underscore the need for innovation
MISTI’s platform combines advanced aerosol science with practical development workflows.
The focus is not just on theory, but on outcomes that translate into measurable improvements.
MISTI’s technology can be applied across:
– Respiratory treatments
– Systemic drug delivery via inhalation
– Biologics and complex formulations
– Early-stage research through to commercial development
We work with teams at different stages to improve performance and reduce risk.
We work closely with pharmaceutical and research teams to integrate our technology into your development process.
Whether you need targeted support or a long-term partner, we adapt to your needs. Our partnerships are designed to:
If delivery is limiting your results, it is time to rethink the approach.
MISTI® helps you develop therapies that perform with greater precision, consistency and confidence.
Find answers about how MedMISTI™ works and what it can do for you
MISTI® uses mesh-free acoustofluidic technology to generate aerosol using high-frequency sound waves, rather than forcing liquid through a physical structure.
This enables more controlled and consistent particle formation, reducing variability and improving delivery performance compared to traditional inhalers and nebulisers.
MISTI® has progressed through prototype development and early user validation, with a working device platform already developed.
Further validation and data will continue to support broader deployment and commercial integration.
MISTI® is designed to support a wide range of inhaled therapies, including:
The platform is particularly valuable where precision, consistency and efficient delivery are critical.
MISTI® is actively seeking partnerships with:
We are focused on working with partners who are looking to push the boundaries of inhaled therapy performance.
MISTI® is a mesh free pulmonary drug delivery technology that uses high frequency acoustic energy and breath actuation to generate controlled aerosol for inhaled therapy.
It is being developed to help medicine reach the lungs more reliably, while supporting treatment visibility through connected use data.
Get updates on emerging threats, platform advances, and best practices from the field
